Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® HIV / AIDS specialty page provides HIV/AIDS-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

HIV / AIDS NEWS - Page 1

ATLAS-2M: Positive Top-Line Results for Long Acting Cabotegravir + Rilpivirine
The study has achieved its primary objective, demonstrating that administration every 8 weeks is as effective in maintaining viral suppression compared with monthly administration.
Youth Born With HIV Face Unique Challenges
Transitioning from a child born with HIV into an adult living with HIV often means less adherence to antiretroviral medication therapies and a lower level of viral suppression. A new study delves into some possible reasons why.
Antiretroviral Safety in Pregnancy: Focus on Dolutegravir, Integrase Inhibitors, and Neural Tube Defects
There has been increasing interest in the association between neural tube defects, dolutegravir, and integrase inhibitors as a class since 4 cases were reported in 2018.
Preclinical Trial of TDF Vaginal Ring for PrEP Ends Early
Research on a tenofovir disoproxil fumarate intravaginal ring for PrEP hit a hurdle when 8 of 12 women unexpectedly developed vaginal ulcers.
FDA Panel Recommends F/TAF for PrEP in MSM and Transgender Women
The committee voted 16 to 2 to recommend F/TAF for PrEP based upon data from the phase 3 DISCOVER study, which evaluated F/TAF in comparison with F/TDF.
Doravirine: Researchers DRIVE for a Drug Ahead of Its Class
A novel NNRTI hits the market, but what place will it have in treatment?
Opioid Injection in Rural US is Challenging Efforts to End the HIV Epidemic
Some rural counties with historically low rates of HIV infection are now experiencing increased risks for HIV transmission of the virus and do not have the infrastructure or resources to respond appropriately.
Outreach Can Provide Needed Boost to Begin, Continue ART
Initiating and adhering to ART is a difficult task for a significant number of people living with HIV. A new study shows that making a concerted effort to find and encourage this population to get the care they need is not an impossible dream.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?